|
|
|
|
Science Sparks @ ACTREC
|
 28 August 2023 |
Vol. No. 12; Issue No. 593 |
|
|
Publications
|
|
1. Nag S, Dikshit R, Desai S, Mane A, Mhatre S, Neve R, Gurav M, Bhosale N, Perumal P, Kembhavi Y, Jethwa D, Badwe R, Gupta S (2023). Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study. Scientific Reports. 13(1): 13551.
2. Rajendra A, Sengar M, Bonda VNA, Jain H, Nayak L, Thorat J, Shet T, Epari S, Laskar S, Aggarwal A, Rangarajan V, Gujral S, Bagal B, Kakoti S, Salvi O (2023). Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL). Leukemia Lymphoma.
Chougule A, Chandrani P, Noronha V, Pange P, Kale S, Nikam A, Nambiar K, Marchande D, Durve A, Gupta V, Jagtap V, Tiwrekar P, Menon N, Joshi A, Kaushal R, Pai T, Patil V, Dutt A, Banavali S, Prabhash K (2023). Real world evidence of EGFR targeted therapy in non-small cell lung cancer– a brief report of decade long single centre experience. JTO Clinical and Research Reports.
Thesis
Anagha Acharekar. 2023. : Understanding the role of radiation induced cell-cell fusion in glioblastoma. (LIFE09201504020) (Guide: Dr. Shilpee Dutt)
|
|
|
|
|
Interesting Reads
|
|
Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, Lettera E, Deyell M, Tavora B, Havel JJ, Phyu SM, Amin AD, Budre K, Kamiya E, Cavallo JA, Garris C, Powell S, Reis-Filho JS, Wen H, Bettigole S, Khan AJ, Izar B, Parkes EE, Laughney AM, Bakhoum SF. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023.
|
|
|
Video of the Week
|
|
| Development of Systemic Therapy in Head and Neck Cancer in Indian Context |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2009 researchers described how a single small intestinal stem cell could expand to crypt-villus organoids in culture without a mesenchymal niche.
|
|
|
|
Cancer News
|
| |
|
Engaging people with low-grade glioma in cancer research
|
|
24 August 2023, National Cancer Institute
|
|
The study, which is part of the Cancer Moonshot initiative, aims to improve the care of people with low-grade glioma by understanding more about the biology of the disease. To achieve this goal, the study is exploring new ways to involve participants in cancer research... |
| |
|
|
|
|
| |
|
|
|
New research sheds light on role of KRAS mutations in pancreatic cancer
|
|
24 August 2023, News-Medical
|
|
This study demonstrated that oncogenic KRAS epigenetically blocks expression of the Fas protein, silencing the pathway and allowing cancer cells to avoid an anti-tumor immune response. Suppressing KRAS led to complete tumor regression and significantly improved survival in these models, suggesting the potential for KRAS inhibition to improve immunotherapy responses and prevent relapse...
|
|
|
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
